ScandiBio Therapeutics AB
AI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Oversigt
- 0
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2017
- Grundlagt
Nøglebeslutningstagere
Dr Özlem Altay
Chief Medical Officer (CMO)
Dr Olof Nord
Chief Executive Officer (CEO)
Prof Mathias Uhlen
Chairman of the Board and co-founder
Dr Adil Marinoglu
Chief Scientific Officer (CSO)
+4 flere kontakter i Funnelfeedr
Beskrivelse
ScandiBio Therapeutics is a Stockholm-based biotechnology company founded by researchers from leading Swedish and UK academic institutions. Their core mission is restoring mitochondrial dysfunction, which they identify as a key factor in many modern health conditions. They leverage AI-based modeling...